3 weeks Alnylam Q3 Loss In Line With Estimates, Revenues Miss, Stock DownZacks

ALNY’s Q3 loss per share matches the Zacks Consensus Estimate and revenues miss the same due to lower collaboration revenues. The stock falls 5.3%.

Earnings · Pharmaceuticals